MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial

OBJECTIVES: To investigate changes in the Apparent Diffusion Coefficient (ADC) using diffusion-weighted imaging (DWI) in men on active surveillance for prostate cancer taking dutasteride 0.5 mg or placebo. METHODS: We analysed 37 men, randomised to 6 months of daily dutasteride (n = 18) or placebo (...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur Radiol
Asıl Yazarlar: Giganti, Francesco, Moore, Caroline M., Robertson, Nicola L., McCartan, Neil, Jameson, Charles, Bott, Simon R. J., Winkler, Mathias, Gambarota, Giulio, Whitcher, Brandon, Castro, Ramiro, Emberton, Mark, Allen, Clare, Kirkham, Alex
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2017
Konular:
Urogenital
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635085/
https://ncbi.nlm.nih.gov/pubmed/28523355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-017-4858-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller